Detecting clinically relevant ALK rearrangements: Comparing the HTG EdgeSeq ALKPlus Assay EU (CE-IVD)to a commercially available ALK FISH assay
Numerous mutations have been shown to drive oncogenesis in non-small cell lung cancer (NSCLC). Measuring these events with conventional methods is difficult given the small amount of material typically collected in the standard needle core biopsy or similar tissue collection method.
- Categories
- White Papers